Press Releases

Hyperthermia Cancer Treatment Market Value, Volume, Growth Predictions, and Forecast to 2022-2030

Share This Article

Rise in Investments in Telemedicine for Access to Cancer Care during COVID-19

Healthcare costs seem to have increased for cancer patients amid the ongoing coronavirus situation, since these patients are at the high risk of contracting the infection, owing to low immunity levels. This has created revenue opportunities for companies in the hyperthermia cancer treatment market, as clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care.

Hospitals and specialty clinics are increasing their investments in developing special screening departments for the evaluation of cancer patients with potential COVID-19 symptoms. Such trends are generating business streams in order to revive growth of the hyperthermia cancer treatment market. However, many clinics have limited and even excluded the amount of visitors that are at the low risk of COVID-19.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111557

Scientists Address Undesired Crystalline Phases in Glass Ceramics for Hyperthermia Techniques

Companies in the hyperthermia cancer treatment market are increasing their R&D in new treatment options for patients. This has led to the emergence of glass ceramics for hyperthermia techniques, owing to their advantages of biocompatibility, bioactivity, and osteoproductivity. However, scientists are yet to explore ways to prevent the occurrence of undesired crystalline phases in the material. Companies are partnering with researchers and scientists to prevent the magnetite oxidation to hematite, which can emerge, while undergoing the heat treatment.

The hyperthermia cancer treatment market is slated to register a favorable CAGR of ~6% during the forecast period. This is evident since glass ceramics in hyperthermia techniques are capable of raising the temperature of cancerous tissues high enough to destroy it.

Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment

The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.

View full report@ https://qyresearchmedical.com/report/hyperthermia-cancer-treatment-market-device-type-infrared-hyperthermia-devices-ultrasound-hyperthermia-devices-microwave-hyperthermia-devices-and-others-treatment-method-locoregional-method-and-whole-body-ap-2020-2030/111557

Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients

The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.

High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.

Strong R&D in Operating Principles of Internal Heating Techniques Improves Medical Outcomes

Combination treatments such as hyperthermia with chemotherapy via controlled localized heating can be achieved with the help of radiofrequency (RF) and microwave. Recent advancements in radiofrequency and microwave mediated hyperthermia include applicators that are most suitable for superficial hyperthermia. On the other hand, internal heating or deep hyperthermia is being combined with brachytherapy i.e. a needle-shaped antenna/electrode that can be implanted directly in the tissue or inserted via catheters.

The high variety in applicator designs for internal heating such as microwave antennas, capacitive-coupled RF catheter-based electrodes, and ultrasound systems are creating value grab opportunities for companies in the hyperthermia cancer treatment market. Med-tech companies are gaining a strong research in operating principles of internal heating techniques and other devices.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111557/2900

Analysts’ Viewpoint

Telemedicine and mobile apps are offering wellness and stress management resources to cancer patients amid the ongoing COVID-19 pandemic. Companies in the hyperthermia cancer treatment market are benefitting with the help of the deep tissue thermal therapy, owing to its non-invasive nature that omits the need of anesthesia. However, radiation dose weighting-based on clonogenic cell survival analysis alone may not be sufficient to predict treatment efficacy. Hence, companies in the hyperthermia cancer treatment market should increase their R&D in more sophisticated biological dose concepts based on spheroid data to improve patient outcomes. Glass ceramics are a breakthrough innovation in the hyperthermia cancer treatment that hold promising potentials with advancements in biomaterial R&D.

Hyperthermia Cancer Treatment Market: Overview

Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.

Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells

Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others

The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies

Hyperthermia Cancer Treatment Market: Drivers

Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.

Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.

Market Segmentation: Hyperthermia Cancer Treatment Market

In terms of device type, the global hyperthermia cancer treatment market has been divided into infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others. The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period.

Based on treatment method, the global hyperthermia cancer treatment market has been bifurcated into locoregional and whole-body. The locoregional segment has been split into external & interstitial, intraluminal or endocavitary methods, continuous hyperthermic peritoneal perfusion (CHPP), and deep tissue & regional perfusion.

In terms of application, the global hyperthermia cancer treatment market has been classified into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others

Based on end user, the global hyperthermia cancer treatment market has been categorized into hospitals & specialty clinics, ambulatory surgical centers, and others. The hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2019.

Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Hyperthermia Cancer Treatment Market

In terms of region, the global hyperthermia cancer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030

The study also offers a list of recommendations, highlights, and useful insights of the global hyperthermia cancer treatment market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Hyperthermia Cancer Treatment Market: Major Players

The hyperthermia cancer treatment market report concludes with the company profiles section, which includes key information about major players in the global hyperthermia cancer treatment market

Leading players analyzed in the hyperthermia cancer treatment market report include

  • Pyrexar Medical
  • Celsius42 GmbH
  • Hydrosun GmbH
  • Oncotherm Kft
  • Andromedic S.r.l.
  • Yamamoto Vinita Co., Ltd.
  • Chongqing Haifu Medical Technology Co., Ltd.
  • innoMedicus Ltd.
  • Gamida
  • RanD

Each of these players has been profiled in the hyperthermia cancer treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Key Questions Answered in Hyperthermia Cancer Treatment Market Report

  • What is the sales/revenue generated by hyperthermia cancer treatment across all regions during the forecast period?
  • What are the opportunities in the global hyperthermia cancer treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which device type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hyperthermia Cancer Treatment Market – Segmentation

Device Type

  • Infrared Hyperthermia Devices
  • Ultrasound Hyperthermia Devices
  • Microwave Hyperthermia Devices
  • Others

Treatment Method

  • Locoregional Method
  • External & Interstitial
  • Intraluminal or Endocavitary Methods
  • Continuous Hyperthermic Peritoneal Perfusion (CHPP)
  • Deep Tissue & Regional Perfusion
  • Whole-body

Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others

End User

  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunity

4.3. Global Hyperthermia Cancer Treatment Market Forecast

4.4. Global Hyperthermia Cancer Treatment Market Outlook

5. Market Outlook

5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

5.2. Epidemiology of Cancer Globally/Country

5.3. Reimbursement Scenario

5.4. Regulatory Scenario

5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia

6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

6.1. Introduction

6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type

6.3.1. Infrared Hyperthermia Devices

6.3.2. Ultrasound Hyperthermia Devices

6.3.3. Microwave Hyperthermia Devices

6.3.4. Others

6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

7.1. Introduction

7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

7.3.1. Locoregional

7.3.1.1. External & Interstitial

7.3.1.2. Intraluminal or Endocavitary Methods

7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

7.3.1.4. Deep Tissue & Regional Perfusion

7.3.2. Whole-body

7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

8. Global Hyperthermia Cancer Treatment Market Analysis, by Application

8.1. Introduction

8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application

8.3.1. Breast Cancer

8.3.2. Liver Cancer

8.3.3. Soft Tissue Sarcoma

8.3.4. Head & Neck Tumors

8.3.5. Prostate Cancer

8.3.6. Others

8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application

9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

9.1. Introduction

9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user

9.3.1. Hospitals & Specialty Clinics

9.3.2. Ambulatory Surgical Centers

9.3.3. Others

9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

10. Global Hyperthermia Cancer Treatment Market Analysis, by Region

10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country

10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region

10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region

10.3.1. North America

10.3.2. Europe

10.3.3. Asia Pacific

10.3.4. Latin America

10.3.5. Middle East & Africa

11. North America Hyperthermia Cancer Treatment Market Analysis

11.1. North America Hyperthermia Cancer Treatment Market Overview

11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country

11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country

11.3.1. U.S.

11.3.2. Canada

11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type

11.5.1. Infrared Hyperthermia Devices

11.5.2. Ultrasound Hyperthermia Devices

11.5.3. Microwave Hyperthermia Devices

11.5.4. Others

11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

11.7.1. Locoregional

11.7.1.1. External & Interstitial

11.7.1.2. Intraluminal or Endocavitary Methods

11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

11.7.1.4. Deep Tissue & Regional Perfusion

11.7.2. Whole-body

11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application

11.9.1. Breast Cancer

11.9.2. Liver Cancer

11.9.3. Soft Tissue Sarcoma

11.9.4. Head & Neck Tumors

11.9.5. Prostate Cancer

11.9.6. Others

11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user

11.11.1. Hospitals & Specialty Clinics

11.11.2. Ambulatory Surgical Centers

11.11.3. Others

12. Europe Hyperthermia Cancer Treatment Market Analysis

12.1. Europe Hyperthermia Cancer Treatment Market Overview

12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

12.3.1. Germany

12.3.2. France

12.3.3. U.K.

12.3.4. Italy

12.3.5. Spain

12.3.6. Rest of Europe

12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type

12.5.1. Infrared Hyperthermia Devices

12.5.2. Ultrasound Hyperthermia Devices

12.5.3. Microwave Hyperthermia Devices

12.5.4. Others

12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

12.7.1. Locoregional

12.7.1.1. External & Interstitial

12.7.1.2. Intraluminal or Endocavitary Methods

12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

12.7.1.4. Deep Tissue & Regional Perfusion

12.7.2. Whole-body

12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application

12.9.1. Breast Cancer

12.9.2. Liver Cancer

12.9.3. Soft Tissue Sarcoma

12.9.4. Head & Neck Tumors

12.9.5. Prostate Cancer

12.9.6. Others

12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user

12.11.1. Hospitals & Specialty Clinics

12.11.2. Ambulatory Surgical Centers

12.11.3. Others

13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis

13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview

13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

13.3.1. Japan

13.3.2. China

13.3.3. India

13.3.4. Australia & New Zealand

13.3.5. Rest of Asia Pacific

13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type

13.5.1. Infrared Hyperthermia Devices

13.5.2. Ultrasound Hyperthermia Devices

13.5.3. Microwave Hyperthermia Devices

13.5.4. Others

13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

13.7.1. Locoregional

13.7.1.1. External & Interstitial

13.7.1.2. Intraluminal or Endocavitary Methods

13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

13.7.1.4. Deep Tissue & Regional Perfusion

13.7.2. Whole-body

13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application

13.9.1. Breast Cancer

13.9.2. Liver Cancer

13.9.3. Soft Tissue Sarcoma

13.9.4. Head & Neck Tumors

13.9.5. Prostate Cancer

13.9.6. Others

13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user

13.11.1. Hospitals & Specialty Clinics

13.11.2. Ambulatory Surgical Centers

13.11.3. Others

14. Latin America Hyperthermia Cancer Treatment Market Analysis

14.1. Latin America Hyperthermia Cancer Treatment Market Overview

14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

14.3.1. Brazil

14.3.2. Mexico

14.3.3. Rest of Latin America

14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type

14.5.1. Infrared Hyperthermia Devices

14.5.2. Ultrasound Hyperthermia Devices

14.5.3. Microwave Hyperthermia Devices

14.5.4. Others

14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

14.7.1. Locoregional

14.7.1.1. External & Interstitial

14.7.1.2. Intraluminal or Endocavitary Methods

14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

14.7.1.4. Deep Tissue & Regional Perfusion

14.7.2. Whole-body

14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application

14.9.1. Breast Cancer

14.9.2. Liver Cancer

14.9.3. Soft Tissue Sarcoma

14.9.4. Head & Neck Tumors

14.9.5. Prostate Cancer

14.9.6. Others

14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user

14.11.1. Hospitals & Specialty Clinics

14.11.2. Ambulatory Surgical Centers

14.11.3. Others

15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis

15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview

15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

15.3.1. GCC Countries

15.3.2. South Africa

15.3.3. Rest of Middle East & Africa

15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type

15.5.1. Infrared Hyperthermia Devices

15.5.2. Ultrasound Hyperthermia Devices

15.5.3. Microwave Hyperthermia Devices

15.5.4. Others

15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

15.7.1. Locoregional

15.7.1.1. External & Interstitial

15.7.1.2. Intraluminal or Endocavitary Methods

15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

15.7.1.4. Deep Tissue & Regional Perfusion

15.7.2. Whole-body

15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application

15.9.1. Breast Cancer

15.9.2. Liver Cancer

15.9.3. Soft Tissue Sarcoma

15.9.4. Head & Neck Tumors

15.9.5. Prostate Cancer

15.9.6. Others

15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user

15.11.1. Hospitals & Specialty Clinics

15.11.2. Ambulatory Surgical Centers

15.11.3. Others

16. Competition Landscape

16.1. Competition Matrix

16.2. Company Profiles

16.2.1. Pyrexar Medical

16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.1.2. Product Portfolio

16.2.1.3. SWOT Analysis

16.2.1.4. Strategic Overview

16.2.2. Celsius42 GmbH

16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.2.2. Product Portfolio

16.2.2.3. SWOT Analysis

16.2.2.4. Strategic Overview

16.2.3. Hydrosun GmbH

16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.3.2. Product Portfolio

16.2.3.3. SWOT Analysis

16.2.3.4. Strategic Overview

16.2.4. Oncotherm Kft

16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.4.2. Product Portfolio

16.2.4.3. SWOT Analysis

16.2.4.4. Strategic Overview

16.2.5. Andromedic S.r.l.

16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.5.2. Product Portfolio

16.2.5.3. SWOT Analysis

16.2.5.4. Strategic Overview

16.2.6. Yamamoto Vinita Co., Ltd.

16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.6.2. Product Portfolio

16.2.6.3. SWOT Analysis

16.2.6.4. Strategic Overview

16.2.7. Chongqing Haifu Medical Technology Co., Ltd

16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.7.2. Product Portfolio

16.2.7.3. SWOT Analysis

16.2.7.4. Strategic Overview

16.2.8. innoMedicus Ltd.

16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.8.2. Product Portfolio

16.2.8.3. SWOT Analysis

16.2.8.4. Strategic Overview

16.2.9. Gamida

16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.9.2. Product Portfolio

16.2.9.3. SWOT Analysis

16.2.9.4. Strategic Overview

16.2.10. RanD.

16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.2.10.2. Product Portfolio

16.2.10.3. SWOT Analysis

16.2.10.4. Strategic Overview

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111557/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button